Dr. Praveen Kumar Kumar Vikraman, MD

Dr. Vikraman practices at Hazard ARH Regional Medical Center in Hazard, Kentucky, part of ARH.

Dr. Vikraman's NPI, 1952888166, was assigned on July 20, 2018. Dr. Vikraman holds Kentucky license 57666.

Dr. Vikraman's primary practice is Hazard ARH Regional Medical Center, at 100 Medical Center Drive, Hazard, KY 41701 in Perry County. The practice phone is (606) 439-1331.

Dr. Vikraman's primary practice is Hazard ARH Regional Medical Center in Hazard, Kentucky, part of ARH. Dr. Vikraman is also affiliated with University of Kentucky Albert B. Chandler Hospital. The medical group on file is ARH Pennington Gap Clinic. Dmand AI also links Dr. Vikraman to 1 more hospital, 1 rural health clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vikraman practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Vikraman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Vikraman's licenses on file in 2 states: Kentucky and New York.

CMS data shows 655 Medicare services from Dr. Vikraman across 3 procedure codes in 2024, for 122 Medicare patients. Medicare paid $54,658 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 122 Medicare patients who saw Dr. Vikraman in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 3.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vikraman's median patient age at 62, with 50% women.

In 2024, Dr. Vikraman wrote 481 Medicare Part D claims for 97 patients. 84% of them were for generic drugs. CMS names the drug for 400 of them, across 14 drugs with 11 or more claims each, at $185,525 in total drug cost. In 2023, CMS named 38 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Vikraman for performance year 2024, reported through an alternative payment model (APM). Dr. Vikraman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 44 general payments to Dr. Vikraman from 11 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $319.